Companies / AUA

AUDEARA LIMITED

ASX:AUAConsumer Durables & Apparel
181.0M shares on issueASX (delayed) · as of 28 July 2026$0.032price · delayed$5.8Mmarket cap · indicative
D
Dilution grade

Runway under 2 quarters; share count grew 25% in 24 months; 3 cash raises in 24 months

Cash runway-0.1 quarters of funding
Share-count growth (24m)24.6%
Raise cadence (24m)3 cash raises
Options & rights overhang19.7% of shares
In-the-money supply0.0% of shares
Pending proposed issuesnone

AUDEARA LIMITED's ordinary share count rose 24.6% between May 2024 and April 2026 to 181M shares. The company completed three capital raises in the 24-month window for total disclosed proceeds of A$1.4M, most recently in December 2024. Options and rights could convert into 36M new shares, equal to 19.7% of the current share count, with the nearest expiry in December 2026 and 0% currently in the money. At the March 2026 quarter AUDEARA reported A$1.5M in cash and a reported cover of -0.1 quarters. No proposed securities issues (Appendix 3B) are pending.

AI-generated summary of this page's cited filings · updated 28 July 2026
Email me when this grade changes
Alerts are coming soon — this opens a pre-filled email that puts you on the list.
19.7%
Max option dilution
0.0%
ITM option dilution
0
Raises · last 12 months
-0.1 qtrs
Cash cover · under 2 quarters

Shares on issue — last 2 years

Ordinary shares on issue
Weekly counts from ASX records. Dots mark cash capital raises. Latest count 181.0M per ASX (delayed) (28 July 2026).
152.7M163.1M173.5MDec 24Sept 25July 26Cash raise · 19 Dec 2024Cash raise · 2 Dec 2024

Cash runway

—
Cover not computed for the latest quarter.
$1.5M available cash at quarter ended 31 Mar 2026 · Runway is computed from Appendix 4C/5B filings and announced raise proceeds.
Paid plan
Cash runway history
Quarterly cash, net spend and cover trend from every Appendix 4C/5B on record up to 31 Mar 2026.
Join the waitlist

Issuance timeline

Latest 5 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)

DateFormSecurityTotal on issue afterSource
14 Apr 20262A · quoted issueAUA : ORDINARY FULLY PAID181.0MAppendix 2A
2 Dec 20253G · unquotedAUA : ORDINARY FULLY PAID179.9MAppendix 3G
2 Dec 20252A · quoted issueAUA : ORDINARY FULLY PAID180.9MAppendix 2A
11 Sept 20253G · unquotedAUA : ORDINARY FULLY PAID179.9MAppendix 3G
10 Mar 20253G · unquotedAUA : ORDINARY FULLY PAID179.9MAppendix 3G
Paid plan
Full issuance history
Every quoted and unquoted issue and cancellation on record, plus unquoted securities (Appendix 4.2).
Join the waitlist

Capital raises

3 cash raises in the last 24 months · 0 in the last 12 months

—
Capital raise
19 Dec 2024
Paid plan
Full raise history
Issue price, discount, brokers, purpose and tranche detail for every raise on record.
Join the waitlist

Pending proposed issues

No proposed issues (Appendix 3B) currently pending.

Options & convertible securities

19.7%
Total overhang · of current shares
0.0%
In the money · at current price
35.7M
Potential new shares
Dec 2026
Nearest expiry
Paid plan
Per-line options & expiry cliffs
Each option line — code, strike, expiry, quantity and ITM value — plus the expiry-cliff chart.
Join the waitlist

Director dealings

DateDirectorTypeSharesOptionsValueSource
26 May 2026David TrimboliBuy75k—$3k3Y notice
12 May 2026David TrimboliBuy71k—$2k3Y notice
2 Dec 2025James FieldingOther11.7M1.8M$25k3Y notice
Paid plan
Full dealing history
Every change-of-director's-interest notice on record, with direction and consideration.
Join the waitlist

Ownership

Free account
Top-20 holders & substantial holder notices
Top-20 register snapshot and substantial-holder movements, each linked to its source notice.
Sign up free — coming soon

Latest announcements

28 May 2026Change of Director's Interest Notice - David Trimboli
15 May 2026Change of Director's Interest Notice - David Trimboli
23 Apr 2026Transition of Chief Technology Officer
15 Apr 2026$PAudeara Secures Exclusive Deal with Shokz Health Global
14 Apr 2026Application for quotation of securities - AUA
13 Apr 2026$PQ3 FY26 Quarterly Activities Report & Appendix 4C
8 Mar 2026$PAuracast platform expansion underway with Clinico Inc
25 Feb 2026$PAppendix 4D & Half-Year Financial Report to 31 December 2025
20 Jan 2026$PQ2 FY26 Quarterly Activities Report & Appendix 4C
17 Dec 2025Clarification to chip-level AI Licensing deal with Optek
15 Dec 2025Audeara secures chip-level AI Licensing deal with Optek
7 Dec 2025$PDecember Trading Update
2 Dec 2025Change of Director's Interest Notice - James Fielding
2 Dec 2025Change of Director's Interest Notice - David Trimboli
2 Dec 2025Change of Director's Interest Notice - Bill Peng
2 Dec 2025Cleansing Notice
2 Dec 2025Notification regarding unquoted securities - AUA
2 Dec 2025Application for quotation of securities - AUA
26 Nov 2025$PNMPA secured for China Hearing Aid Launch
25 Nov 2025$P$1.22m R&D Tax Incentive received

Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 July 2026.